TR
Rhelion Life Sciences Corp.
TRUFF · OTC
$0.02 -2.53% (-$0.00)
1M +9.50%
Market Cap $13.9M
P/E Ratio -
Div. Yield -
ROE 43.00%
Piotroski F-Score Weak
2/9Valuation
70 /100
Cheap P/B 0.74x
P/S 4.52x
EV/FFO N/A
Growth
23 /100
Declining Book val. growth 22.86%
Rev. growth 2.03%
FCF growth N/A
Profitability
14 /100
Weak Op. margin 263.74%
Gross margin 36.80%
FCF margin 129.94%
Quality
2 /100
Poor ROA 30.04%
ROIC 42.04%
Asset turnover 0.14x
Debt
69 /100
Low Int. coverage -97.77x
Debt/Equity 0.02x
Current ratio 3.25x
Stability
47 /100
Moderate EPS volatility 67.06%
Beta 0.96x
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about TRUFF
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Todd Michael Shapiro
Employees
104
Headquarters
Toronto
Upcoming events
30 NOV
Earnings
Upcoming earnings report